NVS terminates Tek ALTITUDE Study Dec 20 News Release

Quote




Anonymous said:
"As a precautionary measure Novartis will cease promotion of Rasilez/Tekturna-based products for use in combination with an ACE-inhibitor or ARB." -Press Release December 20, 2011


http://finance.yahoo.com/news/novartis-announces-termination-altitude-study-061902596.html

http://www.novartis.com/newsroom/media-releases/en/2011/1572562.shtml
Click to expand...

Well, that seals it then....

For hire: Former Tekturna sales representative, mid 40's white male, father of a few. Seeking a new corporate partner for long walks on the beach, fun and misadventure. Was a credible rep in another life. Drank a bit too much corporate Kool-Aid over the past few years and thought Direct Renin Inhibition was answer to all hypertensive ills. Could be that we were wrong...
 




I paid extra for the moon roof, yes I know I was cocky but if I made it through April I'd be sitting pretty under the bright sunny sky...

Can I have my money back please!!!!!
 




Top Bottom
Back
Quote